AI-driven ECG age prediction transforms early disease detection

AI-enabled ECG biological age (ECG-BA) improves disease risk classification beyond chronological age, enhancing early detection of aging-related conditions like heart disease, Alzheimer’s, and cancer.

Risk Adjusted Net Present Value: What is the current valuation of AstraZeneca’s Puxitatug Samrotecan

The revenue for Puxitatug Samrotecan is expected to reach an annual total of $31 mn by 2039 in the US based off GlobalData’s Expiry Model.

September 19, 2023

Feds rein in use of predictive software that limits care for Medicare Advantage patients

Judith Sullivan was recovering from major surgery at a Connecticut nursing home in March when she got surprising news from her Medicare Advantage plan: It

October 5, 2023

Iovance’s TIL therapy plus Keytruda show durable treatment effect in melanoma, but access remains a question

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.